Press release
Transformative Trends Impacting the Late Stage Chronic Kidney Disease Drugs Market Landscape: Product Innovation In Late-Stage Chronic Kidney Disease Drug Market
Late Stage Chronic Kidney Disease Drugs Market
How Large Will the Late Stage Chronic Kidney Disease Drugs Market Size By 2025?
In recent times, the market size for drugs treating late-stage chronic kidney disease has experienced a swift growth. It is projected to rise from $7.08 billion in 2024 to $7.86 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.1%. The substantial growth during the historical period is credited to advancements in diagnosis, the rise of the aging population, increased instances of diabetes and hypertension, heightened knowledge about kidney diseases, and the expansion of pharmaceutical research and development.
How Big Is the Late Stage Chronic Kidney Disease Drugs Market Size Expected to Grow by 2029?
The market for drugs addressing late-stage chronic kidney disease is anticipated to expand considerably in the coming years. The estimated market value is projected to rise to "$12.11 billion by 2029, with a compound annual growth rate (CAGR) of 11.4%. Factors contributing to this expected growth during the forecasted period include increased healthcare spending, the use of precision medicine methodologies, an intensified focus on regenerative medicine, a mounting insistence on patient-focused care, and worldwide actions to raise awareness of kidney disease. Key trends for the forecasted period include the growth of regenerative medicine therapies, the uptake of telemedicine services for chronic kidney disease (CKD) control, the progression of combination therapies, the focus on early intervention methodologies, and a surge in interest in diagnostics based on biomarkers.
View the full report here:
https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report
Which Key Market Drivers Powering Late Stage Chronic Kidney Disease Drugs Market Expansion and Growth?
The escalation in chronic kidney disease occurrences is anticipated to drive the advancements in the late-stage chronic kidney disease drug market. Chronic kidney diseases encompass a wide array of illnesses impacting the kidney's structure and functionality. Late-stage chronic kidney disease pharmaceuticals are meant to regulate the blood pressure of patients and lessen protein loss in order to halt the progression of kidney deficiencies, oversee symptoms, and prevent potential complications. As an illustration, the Centers for Disease Control and Prevention (CDC), a United States-based public health institution, reported in May 2024 that an estimated 14% of U.S. adults, which corresponds to roughly 35.5 million individuals, are suspected to have chronic kidney diseases. Consequently, the commonness of chronic kidney disease is fueling the expansion of the late-stage chronic kidney disease drug market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12196&type=smp
What Trends Will Shape the Late Stage Chronic Kidney Disease Drugs Market Through 2029 and Beyond?
The emergence of product innovation is a significant trend in the late-stage chronic kidney disease drug market. Dominant firms within this field are formulating novel drugs to maintain their footing in the market. Bayer, a pharmaceutical and biotechnology company from Germany, exemplified this in February 2022 when they introduced Kerendia (finerenone) to the Indian market. This medication, a first-of-its-kind non-steroidal, selective mineralocorticoid receptor antagonist, is prescribed for patients suffering from type two diabetes and chronic renal disease. Finerenone functions by inhibiting excessive activation of the mineralocorticoid receptor (MR), believed to contribute to the development of chronic kidney disease (CKD) and potential cardiovascular damage.
What Are the Emerging Segments in the Late Stage Chronic Kidney Disease Drugs Market?
The late stage chronic kidney disease drugs market covered in this report is segmented -
1) By Product Type: Calcimimetics, Vitamin D, Sterols, Potassium Binders, Calcium-Based Phosphate Binders
2) By Indication Type: Late Stage Chronic Kidney Disease Induced Hyperparathyroidism, Late Stage Chronic Kidney Disease Induced Hyperphosphatemia, Late Stage Chronic Kidney Disease Induced Hyperkalemia
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
Subsegments:
1) By Calcimimetics: Cinacalcet, Etelcalcetide
2) By Vitamin D: Calcitriol, Doxercalciferol, Paricalcitol
3) By Sterols: Ergocalciferol, Cholecalciferol
4) By Potassium Binders: Sodium Polystyrene Sulfonate, Patiromer, Sodium Zirconium Cyclosilicate
5) By Calcium-Based Phosphate Binders: Calcium Acetate, Calcium Carbonate
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12196&type=smp
Who Are the Global Leaders in the Late Stage Chronic Kidney Disease Drugs Market?
Major companies operating in the late stage chronic kidney disease drugs market include Pfizer Inc., Johnson & Johnson, AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, C.H. Boehringer Sohn AG & Co. KG, Amgen Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Kyowa Kirin Co Ltd., OPKO Health Inc., Evotec SE, Ionis Pharmaceuticals Inc., Akebia Therapeutics Inc., Ardelyx Inc., Concert Pharmaceuticals Inc., Pharmaxis Limited, Deltanoid Pharmaceuticals Inc., Liminal BioSciences Inc., Chinook Therapeutics Inc., Allena Pharmaceuticals Inc, Shield Therapeutics Plc
Which are the Top Profitable Regional Markets for the Late Stage Chronic Kidney Disease Drugs Industry?
North America was the largest region in the late-stage chronic kidney disease drugs market in 2024. The regions covered in the late-stage chronic kidney disease drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12196
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Transformative Trends Impacting the Late Stage Chronic Kidney Disease Drugs Market Landscape: Product Innovation In Late-Stage Chronic Kidney Disease Drug Market here
News-ID: 4180577 • Views: …
More Releases from The Business Research Company
Pharmaceutical Pellets Market Trends That Will Shape the Next Decade: Insights f …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Pharmaceutical Pellets Market Size By 2025?
The market size for pharmaceutical pellets has seen rapid expansion in recent years. The market value is expected to increase from $1.82 billion in 2024 to $2.01 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.1%.…
Key Trends Influencing the Growth of the Crohn's Disease Treatment Market in 202 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Crohn's Disease Treatment Market Through 2025?
There has been significant expansion in the size of the market for treatment of Crohn's disease in the last few years. It is anticipated to rise from $12.45 billion in 2024 to $13.1 billion in 2025,…
Rising Ophthalmic Disorders Fueling Growth In Ophthalmic Drug Market: Powering I …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Ophthalmic Drugs Market Through 2025?
In recent years, the ophthalmic drugs market has witnessed robust growth. It is projected to escalate from $39.36 billion in 2024 to $42.25 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The growth…
Increasing Incidence Of Chronic Lymphocytic Leukemia Drives Growth In The Cll Ma …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Chronic Lymphocytic Leukemia Treatment Market Size Growth Forecast: What to Expect by 2025?
There has been a robust growth in the market for chronic lymphocytic leukemia treatment in recent years. The market size is estimated to increase from $14.41 billion in 2024 to $15.58 billion in 2025, with a…
More Releases for Late
Late Night Revelry Awaits at The Winslow Lounge - NYC's Premier Late-Night Desti …
Image: https://www.getnews.info/wp-content/uploads/2024/06/1713864312.jpeg
New York, NY - The Winslow Lounge, located in the heart of the East Village, has quickly become the premier late-night destination [https://thewinslownyc.com/late-night-bar-nyc/] in New York City. With its vibrant atmosphere, exciting entertainment options, delicious food and drinks, and lively events, The Winslow offers an unforgettable nightlife experience.
"We wanted to create a place in NYC where people could truly let loose and have an amazing time," said Mark Tafoya,…
Desperate Puppy Seeks Rescue Before It’s Too Late!
FOR IMMEDIATE RELEASE
Tucson AZ, December 14th, 2021
The StarBarksCoffee.com rescue team was recently assaulted and threatened with being shot for assisting an abused, entangled puppy.
This Video of a neglected puppy desperately seeking rescue from a mentally unstable and violently aggressive owner was taken recently at an RV park in Texas during our annual "Journey Across America" in support of Animal Welfare.
We've contacted Texas authorities, but the Sheriff’s Department informed us the…
Transform your Traditional Businesses Before Its Too Late
Mob Inspire, an app development company has disrupted many industries by providing innovative software solutions to traditional businesses. We understand the rapidly changing tech environment and therefore equipt ourselves with those skills and tech tools which enable us to deal with challenging situations efficiently.
Mob Inspire takes the leverage of the latest tech trends like Blockchain, IoT and Cloud to deliver high-end products to its clients. The popularity…
Late-Night Treats for Late-Night Peeps
WHAT: La Motta’s, the neighborhood favorite in Boston’s SoWa District, is rolling out the late-night red carpet for its hospitality industry folks and friends, with Chef de Cuisine Justin Winter’s creative twists on after-hours snacks. Available every Sunday - Thursday from 10:00PM to last call, La Motta’s is the neighborhood joint for a late-night bash with flavorful bites and brews.
Launching Sunday, February 26th, 2017, guests can expect flavorful options…
Late payment – the hidden challenge facing Europe's businesses
A recent Europe-wide business survey has revealed no improvement in the pressure on European businesses from customers’ late payments, with 55 per cent of businesses across Europe reporting late payments resulting in loss of income, 63 per cent claiming additional pressures on liquidity, and 50 per cent citing late payments as having a direct impact on company growth.
In the Republic of Ireland, 47 per cent of businesses surveyed claimed…
Construction in Bulgaria to stabilise in late 2011
In the coming years Bulgaria's construction sector will start to grow slowly following the hard years of the economic slowdown, although no spectacular changes are expected in the short run. After substantial restructuring of the sector moderate construction market recovery in the period 2012-2013 is expected. Until 2015 the sector will grow on the back of the large-scale infrastructure projects related to EU funds.
According to the report “Construction sector in…
